Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (Middle Region) Peptid
Kurzübersicht für Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1) (Middle Region) Peptid (ABIN979610)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Sequenz
- ERQKEFFDSV RSERDDLREE VVMLKEELKK HGIILNSEIA TNGETSDTLN
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LRRFIP1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
-
Hintergrund
-
LRRFIP1 is a transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5'-AGCCCCCGGCG-3') and may regulate expression of TNF, EGFR and PDGFA. LRRFIP1 may control smooth muscle cells proliferation following artery injury through PDGFA repression. LRRFIP1 may also bind double-stranded RNA.
Alias Symbols: FLAP-1, FLAP1, FLIIAP1, GCF-2, GCF2, HUFI-1, TRIP
Protein Interaction Partner: FLII,CTNNB1,EP300,FLII,GRIP1,Grip,MYD88,fliI
Protein Size: 640 -
Molekulargewicht
- 73 kDa
-
Gen-ID
- 9208
-
NCBI Accession
- NM_001137550, NP_001131022
-
UniProt
- E9PGZ2
Target
-